TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.40$ -5.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NRXS
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
88.3% 64.6% 32.2% 47.6% 89.7% 89.5%
67.9% 42.2% 17.1% 15.4% 77.7% 77.5%
67.9% 42.2% 17.1% 15.4% 77.7% 77.5%
11.2% 15.2% 11.8% 14.4% 5.1% 3.1%
3.8% 5.2% 3.3% 4.2% 0.9% 4.0%
10.8% 32.3% – – – –
0.9% 3.2% 5.2% 21.2% 2.0% 4.3%
41.1% 208.6% 476.4% 375.4% 56.5% 46.9%
36.2% 187.4% 471.3% 370.1% 51.1% 43.6%
6.2% 36.6% 35.3% 38.7% 4.6% 3.3%
5.9% 63.6% 107.5% 236.4% 12.5% 2.2%
– 6.8% – – – –
58.9% -108.6% -376.4% -275.4% 43.5% 53.1%
-936.5% -3,833.3% -2,291.7% -9,530.6% -1,193.9% -1,008.7%
193.0% 707.8% 568.1% 1,235.8% 145.4% 141.8%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?